General Information About HIV Medications
- HIV Drug Chart. Chart from Positively Aware’s Drug Guide with basic information about each antiretroviral drug and combination pill or tablet approved by FDA. For each drug or combination, the chart includes: its brand name, generic name, and common abbreviations used; detailed dosing information; and a color image.
- Treatments for HIV and AIDS. Web page from Poz that lists FDA-approved antiretroviral drugs (ARVs), as well as selected experimental drugs. For each drug or combination, the page includes: a small color picture of the pill or tablet, its brand name, generic name, and common abbreviations; and a link to an associated web page with more detailed information about drug, including what it is, how it is dosed, and drug interactions and side effects.
- FDA-Approved HIV Medicines (AIDSinfo) This page has a list of medications used to treat HIV infection, including generic and brand names and date approved by the Food and Drug Administration for use in the United States. For each drug, there is a link to an associated fact sheet with information about that specific medication. Also available in Spanish.
Fact Sheets on Approved Non-Nukes and Combination Pills Containing Non-Nukes
- Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (Poz)
- Nevirapine (Viramune) (AIDS InfoNet) and Spanish version
- Viramune and Viramune XR (Poz)
- Efavirenz (Sustiva, Stocrin) (AIDS InfoNet) and Spanish version
- Sustiva (Poz)
- Delavirdine (Rescriptor) (AIDS InfoNet) and Spanish version
- Rescriptor (Poz)
- Etravirine (Intelence) (AIDS InfoNet) and Spanish version
- Intelence (Poz)
- Rilpivirine (Edurant) (AIDS InfoNet) and Spanish version
- Edurant (Poz)
- Atripla (efavirenz + emtricitabine + tenofovir) (AIDS InfoNet) and Spanish version
- Atripla (Poz)
- Complera (rilpivirine + emtricitabine + tenofovir) (AIDS InfoNet) and Spanish version
- Complera (Poz)
- Odefsey (Emtricitabine/Rilpivirine/Tenofovir Alafenamide (AIDSInfo) and Spanish version
- Odefsey (rilpivirine + emtricitabine + tenofovir alafenamide) (Poz)
Recent Articles About New and Experimental Non-Nukes
- Long-acting injectable drugs work well for HIV maintenance therapy. (July 2016, AIDSmap)
- Early results show doravirine regimen as effective as efavirenz regimen. (March 2016, Project Inform)
- Five Promising HIV Drugs in the Pipeline. (September 2015, TheBodyPro)
- New Antiretrovirals, New Formulations, and New Strategies for HIV Treatment. (August 2015, Beta Blog)
- New HIV Med Doravirine Has Half of Sustiva’s Side Effect Rate. (July 2015, Poz)
- New NNRTI Doravirine Suppresses HIV as Well as Efavirenz but with Fewer Central Nervous System Side-Effects. (July 2015, AIDSmap)
- New NNRTI doravirine as effective as efavirenz in people new to HIV treatment in early study. (July 2015, Project Inform)
- Cabotegravir and rilpivirine effective for HIV maintenance therapy at 96 weeks. (March 2015, AIDSmap)
- HIV maintenance regimen of cabotegravir and rilpivirine looks promising. (March 2015, Project Inform)
- Doravirine works as well as efavirenz with fewer CNS side-effects. (November 2014, AIDSmap)
- Doravirine Study Suggests 100-mg Dose Effective Against Mutant HIV Strains, Too. (November 2014, TheBodyPro)
- Injectable cabotegravir makes progress towards human efficacy studies: doubts about injectable rilpivirine. (October 2014, AIDSmap)
- Antiretroviral studies at ICAAC 2014: darunavir-based FDC with TAF, cobicistat, doravirine, Stribild and gel formulation PrEP. (September/October 2014, HIV Treatment Bulletin)
- Once-a-Month HIV Meds Show Promise in Early Trial. (July 2013, Poz)
- Long-acting GSK1265744 and TMC278-LA appear safe and practical in early study. (July 2013, AIDSmap)
- New NNRTI MK-1439 shows promise in early clinical trial. (March 2013, AIDSmap)